Inventor
Daniel M. Solomon
Inventor
Edison, NJ, US
Overview
Patents· 28 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds44%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
A61KPreparations for medical, dental or toiletry purposes13%
C07CAcyclic or carbocyclic compounds6%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%
C07JSteroids3%
Y02PClimate change mitigation technologies in the production or processing of goods3%
PatentTitleYear
8,524,697'C20-C21 substituted glucocorticoid receptor agonists'20137,879,880'Substituted aniline derivatives useful as histamine H3 antagonists'20117,846,946'Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists'20107,638,531'Phenoxypiperidines and analogs thereof useful as histamine H3 antagonists'20097,635,705'Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists'20097,238,688'Piperidine compounds'20077,220,735'Benzimidazolone histamine H3 antagonists'20077,105,505'Benzimidazole derivatives useful as histamine H3 antagonists'20066,849,621'Piperidine compounds'20056,762,186'Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists'20046,506,756'Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists'20036,211,182'Imidazole compounds substituted with a six or seven membered heterocyclic ring containing two nitrogen atoms'20016,100,279'Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom'20005,939,431'Naphthyridines which affect IL-4 and G-CSF'19995,767,120'Tricyclic derivatives, compositions and methods of use'19985,688,805'Tricyclic derivatives, compositions and methods of use'19975,538,986'Tricyclic derivatives, compositions and methods of use'19965,464,840'Tricyclic derivatives, compositions and methods of use'19955,449,680'2,2 disubstituted glycerol and glycerol-like compounds, compositions and methods of use'19955,185,334'2,2-disubstituted glycerol and glycerol-like compounds, compositions and methods of use'19934,847,377'Substituted-2,3-dihydro-6-substituted-pyrimido[2,1-F]-purine- 4,8(1H,9H)-diones'19894,816,458'Method of treating hyperploliferative skin disease with substituted-2,3-dihydro-6-substituted -pyrimido[2,1]-purine-4,8(1H,9H)diones'19894,666,914'Anti-inflammatory and anti-allergic substituted-2,3-dihydro-6-(hydroxy)pyrimido[2,1-f]-purine-4,8(1H,9H)-dio nes'19874,196,124'1-Benzhydryl-2-benzimidoyl-azetidine'19804,183,923'Antipsoriatic compositions'19804,173,566'1-Benzhydryl-2-cyanoazetidine'19794,140,780'Pharmaceutical compositions comprising N-diphenylalkyl-2-benzyl azacyclic compounds and methods for their use'19794,052,383'N-diphenylalkyl-2-benzyl azacyclic compounds'1977Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1977–2011Patents assigned to SCHERING CORP (26)· patent assignee history
1977–2013Based in Edison, NJ, US· patent location history
2013Patents assigned to ANTHES JOHN C (1)· patent assignee history
2013Patents assigned to ASLANIAN ROBERT G (1)· patent assignee history
2013Patents assigned to BERLIN MICHAEL Y (1)· patent assignee history
2013Patents assigned to BIJU PURAKKATTLE J (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SCHERING CORP | 26 | 1977–2011 |
| ANTHES JOHN C | 1 | 2013 |
| ASLANIAN ROBERT G | 1 | 2013 |
| BERLIN MICHAEL Y | 1 | 2013 |
| BIJU PURAKKATTLE J | 1 | 2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Edison, New Jersey, US | 28 | 1977–2013 |